Isoniazid

This classification denotes an antitubercular agent with the molecular formula C6H7N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V83O1VOZ8L, chemically known as 4-pyridinecarboxylic acid, hydrazide but generally known as isoniazid, which bears US NIH Compound Identifier 3767. European Medicines Agency schedules Isoniazid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08326MIG. The term ISONIAZID is an International Non-Proprietary Name. World Health Organization schedules isoniazid in its Anatomical Therapeutic Chemical (ATC) Classification. ISONIAZID is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoniazid under HS 29333999 and SITC 51574. As of Q4 2014, ISONIAZID remains the US FDA Preferred Term for this commodity. Isoniazid bears US NLM identifiers UMLS ID C0022209 and NCI Concept Code C600. SMILES: O=C(NN)C1CCNCC1.